<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Q</submitter><funding>National Natural Science Foundation of China</funding><funding>Shanghai Municipal Science and Technology</funding><pagination>5033-5054</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12779330</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>66(12)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The BRSK1 gene encodes brain-specific serine/threonine kinase 1 (also known as SAD-B kinase), which is almost exclusively expressed in the brain and plays critical roles in neuronal polarization, neurotransmitter release, mitochondrial dynamics, and neuronal maturation. This study aimed to investigate the pathogenicity of BRSK1 variants in epilepsy and neurodevelopmental disorders.&lt;h4>Methods&lt;/h4>Trio-based exome sequencing was performed in 394 probands with epilepsy. Expression analyses and functional validation were conducted using a newly generated Brsk1 exon 4-7 knockout mouse line (Brsk1&lt;sup>Δ4-7&lt;/sup>), with subsequent behavioral, electrophysiological, proteomic, and phosphoproteomic assessments.&lt;h4>Results&lt;/h4>Six novel BRSK1 variants were identified in seven proba</pubmed_abstract><journal>Epilepsia</journal><pubmed_title>Haploinsufficiency of brain-specific kinase BRSK1 causes epilepsy and neurodevelopmental disorders.</pubmed_title><pmcid>PMC12779330</pmcid><funding_grant_id>2023SHZDZX02</funding_grant_id><funding_grant_id>82302103</funding_grant_id><pubmed_authors>He F</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Yang B</pubmed_authors><pubmed_authors>Liu T</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Xia M</pubmed_authors><pubmed_authors>Peng B</pubmed_authors><pubmed_authors>Shu Y</pubmed_authors><pubmed_authors>Yamanaka H</pubmed_authors><pubmed_authors>Du K</pubmed_authors><pubmed_authors>Jiang YH</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Lu Q</pubmed_authors><pubmed_authors>Luo T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Haploinsufficiency of brain-specific kinase BRSK1 causes epilepsy and neurodevelopmental disorders.</name><description>&lt;h4>Objective&lt;/h4>The BRSK1 gene encodes brain-specific serine/threonine kinase 1 (also known as SAD-B kinase), which is almost exclusively expressed in the brain and plays critical roles in neuronal polarization, neurotransmitter release, mitochondrial dynamics, and neuronal maturation. This study aimed to investigate the pathogenicity of BRSK1 variants in epilepsy and neurodevelopmental disorders.&lt;h4>Methods&lt;/h4>Trio-based exome sequencing was performed in 394 probands with epilepsy. Expression analyses and functional validation were conducted using a newly generated Brsk1 exon 4-7 knockout mouse line (Brsk1&lt;sup>Δ4-7&lt;/sup>), with subsequent behavioral, electrophysiological, proteomic, and phosphoproteomic assessments.&lt;h4>Results&lt;/h4>Six novel BRSK1 variants were identified in seven proba</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T12:51:32.319Z</modification><creation>2026-05-30T03:11:13.679Z</creation></dates><accession>S-EPMC12779330</accession><cross_references><pubmed>41035394</pubmed><doi>10.1111/epi.18621</doi></cross_references></HashMap>